approval
saveCOSENTYX (SECUKINUMAB) — FDA approval
community read0 votes
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalApr 17, 2026
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalApr 17, 2026
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalApr 17, 2026
- approvalZOLEDRONIC ACID — FDA approvalApr 15, 2026
- phase 2 initiationasciminib hydrochloride: Novartis AG — asciminib hydrochloride (Phase II Trial Initiation)Apr 25, 2026
- approvallutetium Lu 177 vipivotide tetraxetan: PLUVICTO (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN) — FDA approvalApr 7, 2026
comments(0)
5-min edit window · permanent after that